MedTrace Logo

CGM Precision and Glycaemic Variability

NCT03842683 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 472

Last updated 2019-11-20

Study results available
· View outcomes & findings →

Summary

Use of devices for continuous monitoring of the blood sugar is valuable for people with diabetes to understand their disease and to help prevent low blood sugar. Furthermore, continuous monitoring should be used in drug development to evaluate efficacy and safety. However, the devices have been criticised for being too inaccurate. This investigation sought to reveal the inaccuracies of current devices and to assess the subsequent usability related to the mentioned use cases.

Conditions

  • Diabetes Type 1

Interventions

OTHER

CGM

This study seeks to assess CGM accuracy and develop prediction models for hypoglycemia detection and no intervention is therefore applied.

Sponsors & Collaborators

  • Peter Vestergaard

    lead OTHER

Principal Investigators

  • Peter Vestergaard, PhD · Steno Diabetes Center North Denmark

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-06
Primary Completion
2017-06-20
Completion
2017-06-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03842683 on ClinicalTrials.gov